For research use only. Not for therapeutic Use.
AKOS-22, also known as AKOS-022075291, is a VDAC1 inhibitor. AKOS-22 inhibits both VDAC1 oligomerization and apoptosis in a concentration-dependent manner.
Catalog Number | I021681 |
CAS Number | 878983-38-1 |
Synonyms | AKOS-22; AKOS 22; AKOS22; AKOS-022075291; AKOS 022075291; AKOS022075291 |
Molecular Formula | C22H21ClF3N3O3 |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | 1-(4-Chloro-phenyl)-3-[4-(4-trifluoromethoxy-phenylamino)-piperidin-1-yl]-pyrrolidine-2,5-dione |
InChI | InChI=1S/C22H21ClF3N3O3/c23-14-1-5-17(6-2-14)29-20(30)13-19(21(29)31)28-11-9-16(10-12-28)27-15-3-7-18(8-4-15)32-22(24,25)26/h1-8,16,19,27H,9-13H2 |
InChIKey | ZZVCWIMICOFQNJ-UHFFFAOYSA-N |
SMILES | O=C(C(N1CCC(NC2=CC=C(OC(F)(F)F)C=C2)CC1)C3)N(C4=CC=C(Cl)C=C4)C3=O |
Reference | Danya Ben-Hail 1 , Racheli Begas-Shvartz 1 , Moran Shalev 1 , Anna Shteinfer-Kuzmine 1 , Arie Gruzman 2 , Simona Reina 3 ,4 , Vito De Pinto 3 and Varda Shoshan-Barmatz 1, * Novel compounds targeting the mitochondrial protein VDAC1 inhibit apoptosis and protect against mitochondria dysfunction. JBC Papers in Press. Published on October 13, 2016 as Manuscript M116.744284. |